Navigation Links
Herbal Preparation Effective For Treating Short Term Low-Back Pain

A new systematic review of studies has found that herbals like of devil's claw, white willow bark and cayenne plasters is highly beneficial for treating shot-term low back pain. // The herbal preparation seems to be equally effective as pain medication and is found to be better than placebo.

The review comprised 10 randomized controlled trials involving nearly 1,600 adults who had acute, sub-acute or chronic low back pain.

The authors looked at randomized controlled trials of the three herbals that involved nearly 1,600 adults with acute, sub-acute or chronic low back pain. The studies pitted devil's claw (Harpago procumbens), white willow bark (Salix alba) and cayenne (Capsicum frutescens) against sham pills and against Vioxx, the painkiller since removed from the market amid concerns over its long-term safety.

“The results of these 10 trials suggest that specific herbal medicines may be effective for short-term (four to six weeks) improvement in pain and functional status for individuals with acute episodes of chronic non-specific low-back pain,” the authors concluded. "These herbal medicines could be considered as treatment options for acute episodes of chronic low back pain," they said.

But the authors cautioned that the long-term efficacy and safety of the herbal treatments remain uncertain because "there is insufficient evidence to make definitive conclusions regarding those trials comparing herbal medicine interventions with standard drugs."

The trials of devil's claw were the strongest in terms of methodology, followed by white willow bark and cayenne, the trials of which were rated "generally of low quality."

Current standard treatments include tissue stimulation, pain medication, exercise and back braces. Drugs and physical activity show the best results, the authors said.

The study found strong evidence that a 50 mg dose of devil's claw was better than placebo in the short term but only moderate evidence for a 100 mg dose.

In a much smaller trial, there did not appear to be any difference between devil's claw and Vioxx.

In a trial of white willow bark versus placebo, the stronger the dose, the more pain relief was found. The stronger dose of white willow bark produced similar pain relief to Vioxx in the short term.

A trial of cayenne plasters produced improvement in pain versus placebo but no difference versus a homeopathic preparation.

“Given that Vioxx was taken off the market due to safety concerns, at this point it would be desirable to recommend all three of the above alternatives for short-term relief, but medication-herbal medicine interactions must always be considered,” Gagnier said, cautioning, “These treatments should not be tried without the supervision of a qualified medical professional,” he said.

Dr. Michael R. Marks, chief of the medical staff at Norwalk Hospital in Connecticut, agreed that herbal treatment may be tried but should not be seen as a replacement for conventional pain killers. “There is probably no reason for the individual without any underlying medical problems not to try these treatments,” Marks said. “But there is really too much unknown about the potential side effects of these medications. A good deal of the herbal medicines prolong bleeding time and interact with anesthetic agents.”

He also said that patients don't always see the potential danger in herbals because they are not regulated. "That is the major concern among the medical community — the lack of consistency of the preparations and exactly what the interactions are with traditional medications.

Source:Newswise
'"/>




Related medicine news :

1. Herbal Drug In Controversy
2. Herbal treatment not to be sneezed at
3. Herbal treatment should be estimated
4. Herbal extract aids in rheumatoid arthritis
5. Herbal supplement ephedra posing threat to peoples health
6. Herbal Remedy Risky for Cancer Patients
7. Herbal remedies can have harmful interaction when taken with drugs for rheumatic arthritis
8. Herbal Remedies For Insomnia And Anxiety May Be Ineffective
9. Herbal remedies to be tested by Zambia for AIDS treatment
10. High concentration of heavy metals in Herbal medicines
11. Law ensuring safety and quality of Herbal drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... ... 20, 2017 , ... ChenMed , a leading provider of value-based care ... Center as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of ... Officer of Ambulatory Services for the UVA Health System, brings 30 years of highly ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia ... that progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and ... and relapse. With such a challenging diagnosis that requires immediate action, patients ...
(Date:7/20/2017)... 20, 2017 (PRWEB) , ... ... ... a global provider of enterprise-grade IT operations analytics and application performance monitoring ... one of world’s largest healthcare services providers. , According to Peter Ohrenberger, ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... For individuals ... utmost importance. The adjustable beds used in such facilities are specially designed to accommodate ... adequate arm support. , An inventor from Rochester, Ind., has invented the patent-pending ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
(Date:7/10/2017)... 2017 Locus Biosciences Inc. today announced the ... development of CRISPR-Cas3 antimicrobial therapeutics. Financing for the round ... Internet services provider, and joined by the North Carolina ... product programs targeting antibiotic resistant infections and other microbiome-related ... Dr. Rodolphe Barrangou and Dr. Charles ...
Breaking Medicine Technology: